FBDIX - Franklin Biotechnology Discovery A
-
Fund Family Name:
Franklin Templeton Investments
-
Expense Ratio:
1.35%
-
ETFdb.com Category:
Health & Biotech Equities
-
Benchmark Index Name:
NASDAQ Biotechnology Index
-
Benchmark Index Description:
The index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc., including a minimum market capitalization of $200 million and an average daily trading volume of at least 100,000 shares. The index is given a semi-annual ranking review to ensure that all components are still able to meet the criteria for inclusion.
Learn more about FBDIX at MutualFunds.com
ETF Alternatives To This Mutual Fund
In the tables below, ETFdb.com presents recommended exchange traded fund (ETF) alternatives to the mutual fund FBDIX. These recommendations are powered by ETFdb's
Mutual Fund to ETF Converter tool.
How ETFdb.com has selected ETF alternatives to FBDIX:
The mutual fund FBDIX has been benchmarked by
Franklin Templeton Investments
against an index,
NASDAQ Biotechnology Index,
in its fund prospectus. The ETF alternatives to FBDIX listed below consist of (1) ETFs which track
NASDAQ Biotechnology Index,
and (2) ETFs which track other indexes in the same ETFdb.com Category as
NASDAQ Biotechnology Index.
ETFs Linked To NASDAQ Biotechnology Index
There are no ETFs linked to NASDAQ Biotechnology Index.
Health & Biotech Equities ETFs
The following table presents exchange traded funds linked to indexes in the same ETFdb.com Category as NASDAQ Biotechnology Index.